Williamson Robert F III

CIK 00013973312 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001397331

Recent Transactions

50 trades

Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2026-03-02+50,000→ 50,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2025-11-12$2.10/sh+9,498→ 9,864 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2025-03-31$2.14/sh+38,145→ 108,982 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2025-03-28$2.27/sh+22,192→ 70,837 total
Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2025-03-03+50,000→ 50,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-11-25$3.62/sh+3,647→ 427,439 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-11-25$3.67/sh+2,619→ 430,058 total
Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2024-06-20+23,000→ 23,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-05-31$1.38/sh+55,000→ 423,792 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-05-29$1.32/sh+11,375→ 350,136 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-05-29$1.34/sh+18,656→ 368,792 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-30$0.70/sh+3,500→ 338,761 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-30$0.72/sh+42,879→ 335,261 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-30$0.71/sh+18,579→ 230,134 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-30$0.71/sh+57,121→ 292,382 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-30$0.71/sh+5,127→ 235,261 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-29$0.64/sh+21,235→ 211,555 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-29$0.64/sh+4,031→ 190,320 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-26$0.59/sh+8,513→ 111,289 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-26$0.61/sh+14,850→ 102,776 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-26$0.55/sh+25,000→ 136,289 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-26$0.61/sh+12,250→ 87,926 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-26$0.54/sh+50,000→ 186,289 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-25$0.49/sh+22,134→ 75,676 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-01-24$0.49/sh+29,862→ 53,542 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-12-21$0.33/sh+3,663→ 3,663 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-12-19$0.32/sh+13,680→ 23,680 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-12-18$0.26/sh+10,000→ 10,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-12-12+230,000→ 930,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-02-21+470,000→ 470,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-02-21+230,000→ 700,000 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−13,333.33→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−15,000→ 0 total
Disposition from Tender
Pharmasset Inc
Common Stock
2012-01-12$137.00/sh−7,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−20,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−40,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−13,333.33→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−40,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−16,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−20,000→ 0 total
Disposition to Issuer
Pharmasset Inc
Stock Option (Right to Buy)
2012-01-12−40,000→ 0 total
Award
Pharmasset Inc
Common Stock, $.001 par value per share
2011-10-11+1,000→ 7,000 total
Award
Pharmasset Inc
Stock Option (Right to Buy)
2011-10-11+15,000→ 15,000 total
Exercise/Conversion
Pharmasset Inc
Stock Option (Right to Buy)
2011-05-06−20,000→ 0 total
Sale
Pharmasset Inc
Common Stock, $.001 par value per share
2011-05-06$104.36/sh−31,666→ 3,000 total
Exercise/Conversion
Pharmasset Inc
Common Stock, $.001 par value per share
2011-05-06$3.00/sh+20,000→ 34,666 total
Award
Pharmasset Inc
Common Stock, $.001 par value per share
2011-03-23+2,000→ 14,666 total
Award
Pharmasset Inc
Stock Option (Right to Buy)
2010-10-14+20,000→ 20,000 total
Award
Pharmasset Inc
Common Stock, $.001 par value per share
2010-03-18+2,000→ 12,666 total
Award
Pharmasset Inc
Stock Option (Right to Buy)
2009-10-14+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O PERSPECTIVE THERAPEUTICS, INC. 2401 ELLIOTT AVENUE, SUITE 320

SEATTLE, WA, 98121

View on SEC.gov